This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Marc O'Reilly
Introduction
Marc O'Reilly is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific protein kinases. His work is particularly relevant in the context of cancer treatment, showcasing the potential of innovative therapies.
Latest Patents
Marc O'Reilly holds a patent for "Benzolactam compounds as protein kinase inhibitors." This invention provides a compound that acts as an inhibitor of ERK1/2 kinases. The compounds developed by O'Reilly are useful in the treatment of ERK1/2-mediated conditions, making them valuable in therapeutic applications, especially in cancer treatment. He has 1 patent to his name.
Career Highlights
O'Reilly is currently associated with Otsuka Pharmaceutical, a company known for its commitment to innovative healthcare solutions. His work at Otsuka has allowed him to focus on developing new therapeutic options that can significantly impact patient care.
Collaborations
Throughout his career, Marc O'Reilly has collaborated with esteemed colleagues such as Valerio Berdini and Ildiko Maria Buck. These collaborations have further enriched his research and contributed to the advancement of his innovative projects.
Conclusion
Marc O'Reilly's contributions to the field of medicinal chemistry and his innovative patent for protein kinase inhibitors highlight his role as a significant inventor in the healthcare industry. His work continues to pave the way for new therapeutic approaches in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile